Company press releases

Displaying 101 - 109 of 109 results
Released Company Title Industry Topic
21 Sep 2021
18:15 CEST 		NFL BIOSCIENCES S.A. NFL BIOSCIENCES: approval for its patent to be granted in the United States 20103010 Biotechnology -
21 Sep 2021
18:15 CEST 		NFL BIOSCIENCES S.A. NFL BIOSCIENCES : Accord de délivrance de son brevet aux États-Unis 20103010 Biotechnology -
15 Sep 2021
18:00 CEST 		NFL BIOSCIENCES S.A. NFL BIOSCIENCES: Phase II/III clinical trial for NFL-101 for smoking cessation approved in Franc 20103010 Biotechnology -
15 Sep 2021
18:00 CEST 		NFL BIOSCIENCES S.A. NFL Biosciences : l’étude clinique de Phase II/III de NFL-101 pour le sevrage tabagique approuvée en France 20103010 Biotechnology -
06 Sep 2021
08:45 CEST 		NFL BIOSCIENCES S.A. NFL BIOSCIENCES: ANALYST COVERAGE LAUNCHED WITH INVEST SECURITIES 20103010 Biotechnology -
06 Sep 2021
08:45 CEST 		NFL BIOSCIENCES S.A. NFL BIOSCIENCES : INITIATION DE COUVERTURE ANALYSTE PAR INVEST SECURITIES 20103010 Biotechnology -
20 Jul 2021
08:00 CEST 		NFL BIOSCIENCES S.A. NFL BIOSCIENCES : MISE EN PLACE D’UN CONTRAT DE LIQUIDITE 20103010 Biotechnology -
05 Jul 2021
08:00 CEST 		NFL BIOSCIENCES S.A. Nfl Biosciences Raises €5.0m Following Its Successful Initial Public Offering on Euronext Growth Paris® 20103010 Biotechnology -
30 Jun 2021
19:50 CEST 		NFL BIOSCIENCES S.A. NFL BIOSCIENCES LÈVE 5,0 M€ SUITE AU SUCCÈS DE SON INTRODUCTION EN BOURSE SUR EURONEXT GROWTH PARIS® 20103010 Biotechnology -